OS of non-Ph patients according to chromosomal risks and allo-HCT period. Results are adjusted for age at allo-HCT, white blood cell at diagnosis, conditioning intensity (myeloablative conditioning, RIC), donor source (related, unrelated bone marrow, unrelated cord blood), and disease status (CR1, subsequent CR, non-CR). (A) Adjusted OS of non-Ph patients with high-risk chromosomal abnormalities. (B) Adjusted OS of non-Ph patients with standard-risk chromosomal abnormalities.